Tyvyt
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Tyvyt, covering 2024-07-03 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC [Phase 2]